Literature DB >> 26123616

Experiences of diagnosis, care and treatment among Aboriginal people living with hepatitis C.

Loren Brener1, Hannah Wilson1, L Clair Jackson1, Priscilla Johnson1, Veronica Saunders1, Carla Treloar1.   

Abstract

OBJECTIVE: Aboriginal Australians are disproportionately affected by hepatitis C (HCV). There are a range of barriers to HCV care, often beginning with poor diagnosis experiences. Little research exists on the experiences of Aboriginal Australians living with HCV. This study aimed to describe their patterns of HCV care and treatment with specific emphasis on the impact of their being informed of their diagnosis in a culturally sensitive manner.
METHODS: A total of 203 Aboriginal people living with HCV were recruited to complete a survey assessing experiences of HCV testing and care, HCV knowledge, lifestyle changes after diagnosis, perceived stigma and discrimination.
RESULTS: Of the sample, 58% were male and 96% identified as Aboriginal, with a mean age of 28 years. Correlation analysis revealed that satisfaction with the cultural appropriateness of the diagnosis was associated with: being offered pre- and post-test counselling; satisfaction with HCV care; decreased feelings of HCV-related stigma; lower scores on the medical mistrust scale; and greater intentions to access HCV treatment.
CONCLUSIONS: These findings confirm the importance of providing a HCV diagnosis in a culturally appropriate way for Aboriginal people. IMPLICATIONS: Satisfaction with HCV diagnosis appears essential in establishing patterns of greater engagement with HCV care and treatment for this group.
© 2015 The Authors.

Entities:  

Keywords:  Aboriginal people; Australia; care; diagnosis; hepatitis C; treatment

Mesh:

Year:  2015        PMID: 26123616     DOI: 10.1111/1753-6405.12402

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  8 in total

1.  Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.

Authors:  M Eugenia Socías; Lianping Ti; Evan Wood; Ekaterina Nosova; Mark Hull; Kanna Hayashi; Kora Debeck; M-J Milloy
Journal:  Liver Int       Date:  2019-02-24       Impact factor: 5.828

2.  COVID-19 vaccine hesitancy and patient self-advocacy: a statistical analysis of those who can and can't get vaccinated.

Authors:  Douglas Ashwell; Joanna Cullinane; Stephen M Croucher
Journal:  BMC Public Health       Date:  2022-07-05       Impact factor: 4.135

3.  Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada.

Authors:  Lindsay A Pearce; Fahmida Homayra; Laura M Dale; Soroush Moallef; Brittany Barker; Alexa Norton; Kanna Hayashi; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2020-07-27

4.  Ubiquitous Yet Unclear: A Systematic Review of Medical Mistrust.

Authors:  Ramona Benkert; Adolfo Cuevas; Hayley S Thompson; Emily Dove-Meadows; Donulae Knuckles
Journal:  Behav Med       Date:  2019 Apr-Jun       Impact factor: 3.104

5.  CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.

Authors:  Sarah Schillie; Carolyn Wester; Melissa Osborne; Laura Wesolowski; A Blythe Ryerson
Journal:  MMWR Recomm Rep       Date:  2020-04-10

6.  "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments.

Authors:  Trevor Goodyear; Helen Brown; Annette J Browne; Peter Hoong; Lianping Ti; Rod Knight
Journal:  Int J Equity Health       Date:  2021-03-19

7.  Seldom heard voices: a meta-narrative systematic review of Aboriginal and Torres Strait Islander peoples healthcare experiences.

Authors:  Benjamin Jones; David Heslop; Reema Harrison
Journal:  Int J Equity Health       Date:  2020-12-14

8.  Evaluation of the Deadly Liver Mob program: insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care.

Authors:  Carla Treloar; Max Hopwood; Elena Cama; Veronica Saunders; L Clair Jackson; Melinda Walker; Catriona Ooi; Ashley Ubrihien; James Ward
Journal:  Harm Reduct J       Date:  2018-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.